Yes. Our time line is as follows: we're 2 months now, a little bit beyond 2 months into the merger. I think things are going really well as far as the people side. Our sales teams are coming together. Our credit teams are coming together. We're doing a lot of training. I think a lot of the Community Bank folks are drinking from a firehose with that, but they're really, they really impressed me with the way that they have embraced the challenge. In terms of our operations or conversion on the data processing, the Pfizer side. And I'll repeat this if some of you don't know. They're on Pfizer, we're on Pfizer, we're both on the same type of Pfizer, which is called Premier. However, they run an external model, we run an inside model. And so there are still challenges with any conversion, but we feel like given those facts, the conversion should potentially go smoother than if they were on a completely system, a different system overall. That conversion is taking place over the weekend of November 10, 11 and 12, which is the Veterans Day weekend, I believe. Then, in the first quarter, first 4 months really of 2019, we will consolidate the locations. And so far, we have, we're going to consolidate between 8 and 10 locations. We haven't decided whether we're going to do a full 10 or just the 8, that will be at least 8 and as many as 10, and we'll make that decision shortly. And those will roll out through January into early may. And so by the midpoint of May, we should be fully integrated. Everything should be together. There should be no more onetime costs or acquisition costs, et cetera, et cetera. I do think you're going to see a lot of acquisition expenses in the fourth quarter, in the first quarter of 2019, but by the second quarter of 2019, those, most of those will dissipate and we will be business as usual.